PDG38 ASSESSMENT OF GENERIC COMPETITION FOR ORPHAN DRUGS MARKETED IN THE US (1993-2019)

Abstract

Authors

B. Ghanem H. Althobaiti G. Phillipe R. Rodriguez-Monguio E. Seoane-Vazquez

Full Text Cite This Article
Back to Volume 23, Supplemental S1
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×